Lineage
LINE
34.21
-0.23
-0.67%
Lineage
US · LINE
#1687 by market cap
Listed 2024
34.21
-0.23
-0.67%
Live - 5344 symbols - heartbeat 287s ago
· 2026-10-07 19:54
After-hours
34.21
0.00%
- Market cap
- 7.79B
- P/E (TTM)i
- -47.51
- P/Bi
- 0.99
- EPSi
- -0.43
- Div yieldi
- 6.20%
- 52W posi
- 28%
Reader sentiment
Are you bullish or bearish on LINE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.60, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +0.28% YoY
Margins
- Gross margin
- 32.14%
- Operating margin
- 4.71%
- Net margin
- -1.87%
Key ratios & quality
- Enterprise valuei
- 13.83B
- Altman Z-Scorei
- 0.60
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 3.70B | 4.93B | 5.34B | 5.34B | 5.36B |
| Gross profit | 1.13B | 1.46B | 1.75B | 1.76B | 1.72B |
| Selling & admin expenses | 289.30M | 399.00M | 502.00M | 539.00M | 574.00M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | 237.60M | 378.00M | 490.00M | 347.00M | 252.00M |
| Pretax profit | -205.80M | -70.00M | -110.00M | -840.00M | -115.00M |
| Tax | -29.30M | 6.00M | -14.00M | -89.00M | -2.00M |
| Net profit | -176.50M | -76.00M | -96.00M | -751.00M | -113.00M |
| Basic EPS | -1 | 0 | 0 | -4 | 0 |
| Diluted EPS | -0.69 | -0.29 | -0.35 | -3.70 | -0.43 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.29B | 1.35B | 1.38B | 1.34B | 1.30B | 1.36B |
| Gross profit | 416.00M | 430.00M | 445.00M | 430.00M | 417.00M | 425.00M |
| Selling & admin expenses | 154.00M | 143.00M | 145.00M | 132.00M | 141.00M | 138.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 50.00M | 63.00M | 70.00M | 69.00M | 43.00M | 50.00M |
| Pretax profit | 8.00M | -14.00M | -101.00M | -8.00M | -47.00M | -33.00M |
| Tax | 8.00M | -7.00M | 11.00M | -14.00M | 4.00M | -1.00M |
| Net profit | 0 | -7.00M | -112.00M | 6.00M | -51.00M | -32.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.01 | -0.03 | -0.44 | 0.03 | -0.18 | -0.13 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | 1.24B | 1.40B | 1.26B | 1.29B | 1.24B |
| Cash & ST investments | 209.10M | 170.60M | 68.00M | 175.00M | 66.00M |
| Inventory | 144.50M | 156.80M | 171.00M | 187.00M | 145.00M |
| Total assets | 16.42B | 18.56B | 18.87B | 18.66B | 19.19B |
| Total current liabilities | 1.05B | 1.22B | 1.37B | 1.49B | 1.55B |
| Short-term debt | 19.50M | 36.40M | 24.00M | 56.00M | 2.00M |
| Long-term debt | 7.57B | 8.70B | 8.96B | 4.91B | 6.11B |
| Total liabilities | 11,141,800,000.00 | 12,451,700,000.00 | 12,849,000,000.00 | 8,967,000,000.00 | 9,942,000,000.00 |
| Total equity | 5.28B | 6.11B | 6.02B | 9.69B | 9.24B |
| Retained earnings | -667.00M | -712.80M | -879.00M | -1.86B | -2.44B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.39B | 1.35B | 1.28B | 1.24B | 1.26B | 1.24B |
| Cash & ST investments | 195.00M | 81.00M | 74.00M | 66.00M | 67.00M | 58.00M |
| Inventory | 175.00M | 174.00M | 167.00M | 145.00M | 137.00M | 122.00M |
| Total assets | 18.77B | 19.44B | 19.20B | 19.19B | 19.05B | 18.90B |
| Total current liabilities | 1.41B | 1.41B | 1.29B | 1.55B | 1.49B | 1.59B |
| Short-term debt | 55.00M | 32.00M | 22.00M | 2.00M | 2.00M | 2.00M |
| Long-term debt | 5.13B | 5.74B | 5.93B | 6.11B | 6.26B | 6.22B |
| Total liabilities | 9,122,000,000.00 | 9,778,000,000.00 | 9,812,000,000.00 | 9,942,000,000.00 | 9,993,000,000.00 | 10,026,000,000.00 |
| Total equity | 9.65B | 9.67B | 9.39B | 9.24B | 9.06B | 8.87B |
| Retained earnings | -1.98B | -2.10B | -2.33B | -2.44B | -2.61B | -2.76B |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 329.90M | 501.00M | 796.00M | 703.00M | 943.00M |
| Depreciation & amortization | 603.70M | 678.00M | 760.00M | 876.00M | 895.00M |
| Free cash flow | -359.20M | -312.00M | 30.00M | 12.00M | 196.00M |
| Dividends paid | -148.40M | -180.00M | -46.00M | -234.00M | -537.00M |
| Stock buybacks / issuance | 2.08B | 934.00M | 112.00M | 4.76B | -82.00M |
| Ending cash balance | 240.10M | 202.00M | 71.00M | 175.00M | 66.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 139.00M | 258.00M | 230.00M | 316.00M | 130.00M | 311.00M |
| Depreciation & amortization | 212.00M | 224.00M | 230.00M | 229.00M | 233.00M | 237.00M |
| Free cash flow | -12.00M | 95.00M | 35.00M | 78.00M | -55.00M | 186.00M |
| Dividends paid | -134.00M | -134.00M | -134.00M | -135.00M | -133.00M | -136.00M |
| Stock buybacks / issuance | -- | -- | -- | -54.00M | -- | -- |
| Ending cash balance | 197.00M | 82.00M | 75.00M | 66.00M | 67.00M | 58.00M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -3.53 | -1.59 | -8.56 | -9.70 | -1.18 |
| ROA %i | -0.93 | -0.43 | -2.33 | -3.54 | -0.53 |
| ROIC %i | 0.32 | 1.22 | -1.47 | -1.38 | 1.37 |
| 5-year avg ROE %i | -- | -- | -- | -- | -3.45 |
| EBIT margin %i | 0.79 | 5.45 | -5.76 | -6.16 | 4.03 |
| FCF / sales %i | -- | -- | 0.55 | 0.22 | 3.66 |
| Current ratioi | 1.19 | 1.15 | 0.92 | 0.86 | 0.80 |
| Quick ratioi | 0.86 | 0.91 | 0.72 | 0.67 | 0.62 |
| Debt / assetsi | 58.50 | 57.60 | 58.55 | 36.86 | 41.64 |
| LT debt / equityi | 220.91 | 206.20 | 218.32 | 78.98 | 96.86 |
| Interest coveragei | 0.12 | 0.77 | -1.39 | -0.64 | 0.65 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 12.99 | 2.81 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -7.17 | -8.12 | -2.03 | -1.18 | -1.72 | -2.01 |
| ROA %i | -3.29 | -2.87 | -0.92 | -0.53 | -0.76 | -0.87 |
| ROIC %i | -1.51 | -1.56 | 0.61 | 1.37 | 1.09 | 1.03 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -6.49 | -6.88 | 1.81 | 4.03 | 3.10 | 2.79 |
| FCF / sales %i | 0.79 | 3.16 | 3.17 | 3.66 | 2.85 | 4.54 |
| Current ratioi | 0.99 | 0.96 | 0.99 | 0.80 | 0.85 | 0.78 |
| Quick ratioi | 0.74 | 0.69 | 0.72 | 0.62 | 0.66 | 0.62 |
| Debt / assetsi | 37.76 | 39.48 | 40.80 | 41.64 | 42.28 | 42.28 |
| LT debt / equityi | 81.89 | 88.51 | 93.18 | 96.86 | 99.54 | 101.22 |
| Interest coveragei | -0.80 | -1.05 | 0.30 | 0.65 | 0.49 | 0.44 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Global Warehousing is the largest reported line at 73.84% of revenue, across 2 reported segments.
- The next-largest line, Global Integrated Solutions, is a distant second at 26.16% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Global Warehousing73.84%
Global Integrated Solutions26.16%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.